These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 32957448
1. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants. S Santos L, M Gil O, N Silva S, C Gomes B, C Ferreira T, Limbert E, Rueff J. Genes (Basel); 2020 Sep 17; 11(9):. PubMed ID: 32957448 [Abstract] [Full Text] [Related]
2. Correlation between micronuclei frequency in peripheral blood lymphocytes and retention of 131-I in thyroid cancer patients. Vrndić OB, Milošević-Djordjević OM, Mijatović Teodorović LC, Jeremić MZ, Stošić IM, Grujicić DV, Zivancević Simonović ST. Tohoku J Exp Med; 2013 Feb 17; 229(2):115-24. PubMed ID: 23337621 [Abstract] [Full Text] [Related]
3. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis. Joseph LJ, Bhartiya US, Raut YS, Kand P, Hawaldar RW, Nair N. Mutat Res; 2009 Apr 30; 675(1-2):35-40. PubMed ID: 19386245 [Abstract] [Full Text] [Related]
4. Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer. Vrndic O, Milosevic-Djordjevic O, Djurdjevic P, Jovanovic D, Mijatovic L, Jeftic I, Simonovic SZ. Neoplasma; 2013 Apr 30; 60(5):568-75. PubMed ID: 23790177 [Abstract] [Full Text] [Related]
5. Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature. Zhang X, Liu DS, Luan ZS, Zhang F, Liu XH, Zhou W, Zhong SF, Lai H. Clin Transl Oncol; 2018 Jul 30; 20(7):928-935. PubMed ID: 29119458 [Abstract] [Full Text] [Related]
14. Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility. Santos LS, Silva SN, Gil OM, Ferreira TC, Limbert E, Rueff J. Oncol Lett; 2018 May 30; 15(5):6715-6726. PubMed ID: 29616133 [Abstract] [Full Text] [Related]
15. Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles. Park SY, Kim HI, Choi JY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Ahn SH, Kim K, Jeong JG, Kim SW, Chung JH, Kim TH. Oral Oncol; 2018 Sep 30; 84():41-45. PubMed ID: 30115474 [Abstract] [Full Text] [Related]
16. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Albano D, Bertagna F, Panarotto MB, Giubbini R. Pediatr Blood Cancer; 2017 Nov 30; 64(11):. PubMed ID: 28436606 [Abstract] [Full Text] [Related]
17. Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. Serna A, Alcaraz M, Navarro JL, Acevedo C, Vicente V, Canteras M. Radiat Prot Dosimetry; 2008 Nov 30; 129(4):372-80. PubMed ID: 17951242 [Abstract] [Full Text] [Related]